ramucirumab,pembrolizumab
eli lilly,merck
['s1800a', 'lung']
dr. of on #asco22 #jco simultaneous publication on randomized phase ii trial lung-map s1800a "this offers a new option for patients without chemotherapy and can be potentially practice changing." read in jco 
@ASCO's credible, authoritative resource for disseminating clinical oncology research. Home of @JCOOP_ASCO, @JCOGO_ASCO, @JCOCCI_ASCO, & @JCOPO_ASCO.